表紙:米国網膜アトラス(2021年):Med/Op Index(TM)インデックスによる分析
市場調査レポート
商品コード
1009630

米国網膜アトラス(2021年):Med/Op Index(TM)インデックスによる分析

2021 United States Retina Atlas Featuring the Market Scope Exclusive MedOp Index(TM) Analysis

出版日: | 発行: Market Scope, LLC | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.57円
米国網膜アトラス(2021年):Med/Op Index(TM)インデックスによる分析
出版日: 2021年06月09日
発行: Market Scope, LLC
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、米国の網膜疾患市場に焦点を当て、Med/Op Indexに基づいて、米国の85都市の人口統計、網膜治療の機会、都市圏別の網膜手術件数および網膜専門医数の推計、市場の戦略的洞察、硝子体内(IVT)投与および硝子体手術を実施する眼科診療所に関する情報などをまとめています。

硝子体(IVT)注射および硝子体手術の施術件数:都市圏別

目次

The Retina Atlas offers strategic insights into the top potential markets in the US by providing demographic information of selected metropolitan populations; profiles of selected metropolitan areas and applicable retinal treatment opportunity; current estimates for retina surgery volume by metropolitan area; current estimates for retina surgeons by metropolitan area; and a comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies.

The allocation of the population with retinal disease is calculated by combining the prevalence rates by age group from Market Scope's comprehensive retinal disease model with the age distribution of each geography. We also consider the varying rates of adult diabetes throughout the US. The different procedure volumes and practice size are considered in the distribution of procedures. Retinal treatment opportunity is estimated with multi-factor criteria using Market Scope's MedOp Index™ Analysis. Factors in this analysis include the demographic makeup of a geography-including age distribution and health metrics-and the volume and concentration of retina surgeons.

The "2021 United States Retina Atlas"provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. The atlas identifies potential based on a variety of factors, which allows us to rank metros by opportunity and offers strategic insights into the top potential markets in the US.

Featured in the atlas is the Med/Op Index™ Analysis, a proprietary new index developed to estimate the market opportunity for each metropolitan area. This proprietary index identifies the potential based on patient demographics, procedure volumes, retina providers, and other factors.

The Retina Atlas can be used to evaluate market potential, identify growth opportunities, and allocate sales resources.